Immunosuppressive efficacy of mycophenolate mofetil when compared with azathioprine and mizoribine against peripheral lymphocytes from renal transplant recipients

Transplant International

Volumn 18, Issue 5, 2005, Pages 590-595

  Sugiyama, Kentaro ^a   Satoh, Hiroshi ^a   Saito, Kazuhide ^b   Takahashi, Kota ^b   Saito, Noriko ^b   Hirano, Toshihiko ^c  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

3 (4,5 dimethylthiazol 2 yl) 2,5 diphenyl tetrazolium bromide (MTT); Azathioprine; Mizoribine; Mycophenolate acid; Mycophenolate mofetil; Peripheral blood mononudclear cells

Indexed keywords

BASILIXIMAB; CONCANAVALIN A; CYCLOSPORIN A; MERCAPTOPURINE; METHYLPREDNISOLONE; MIZORIBINE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PURINE; TACROLIMUS; AZATHIOPRINE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; NUCLEIC ACID SYNTHESIS INHIBITOR; RIBONUCLEOSIDE;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; IC 50; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; KIDNEY TRANSPLANTATION; LIVER DISEASE; LYMPHOCYTE TRANSFORMATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PURINE SYNTHESIS; TREATMENT OUTCOME; VIRUS INFECTION; CASE CONTROL STUDY; COMPARATIVE STUDY; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MIDDLE AGED;

6-MERCAPTOPURINE; ADULT; AZATHIOPRINE; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; NUCLEIC ACID SYNTHESIS INHIBITORS; RIBONUCLEOSIDES;

EID: 23844556557     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2005.00093.x     Document Type: Article

References (15)

1. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 61: 1029.
2. The Mycophenplate Mofetil Acute Renal Rejection Study Group. Mycophenlate mofetil for the treatment of a first acute renal allograft rejection. Transplantation 1998; 65: 235.
3. Joel GH, Alfred GG, Lee EL. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th edn. Macmillan: New York, 1995.
4. Lu G, Mohammad RS, Satoshi S, Akira M, Gregory AP, Lizbeth H. The immunosuppressive agent mizoribine monophosphate forms a transition state analogue complex with inosine monophosphate dehydrogenase. Biochemistry 2003; 42: 857.
5. Sugiyama K, Kawada T, Satoh H, Hirano T. Comparison of suppressive potency between prednisolone and prednisolone sodium succinate against mitogen-induced blastogenesis of human peripheral blood mononuclear cells in-vitro. J Pharm Pharmacol 2001; 53: 727.
6. William AL, Leo G, Andrew RM, Nancy C, Kwan L, Peter HN. Bioavailability improvement of mycophenolic acid through amino ester derivatization. Pharm Res 1990; 7: 161.
7. Sugiyama K, Satoh H, Hirano T. Comparison of suppressive potency between azathioprine and 6-mercaputopurine against mitogen-induced blastogenesis of human peripheral blood mononuclear cells in-vitro. J Pharm Pharmacol 2003; 55: 393.
8. Hirano T, Oka K, Takeuchi H, et al. Clinical significance of glucocorticoid pharmacodynamics assessed by anti-lymphocyte action in kidney transplantation. Transplantation 1994; 57: 1341.
9. Hirano T, Oka K, Takeuchi H, et al. Immunosuppressant pharmacodymamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis and psoriasis: possible implications for individual therapeutic efficacy. Clin Pharmacol Ther 1997; 62: 652.
10. Hirano T, Abe K, Gotoh M, Oka K. Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br J Cancer 1995; 72: 1380.
11. Jon K, Leslie M, Dale R, et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Transplantation 1998; 66: 507.
12. Russell W, John R, Goran K, et al. A randomized double-blind comparative study of mycophenolate mofetil and azathiopurine in combination with cyclosporin and corticosteroids in primary liver transplant recipients. Liver Transpl 2001; 7: 442.
13. Scott MP, Maher AB, Linda S, et al. Results of a randomized prospective multicentre trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection. Transplantation 2001; 71: 1772.
14. David JR, Paul FW, Michel L, Michel K, Shelly R, Robert MK. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation preliminary experience. J Heart Lung Transplant 1998; 17: 768.
15. Anthony CA. Approaches to the design of immunosuppressive agents. In: The molecular biology of immunosupression. John Wiley & Son Ltd, 1992: 181.